[Artificial intelligence in the management of anti-VEGF treatment: the Vienna fluid monitor in clinical practice]. / Künstliche Intelligenz im Management der Anti-VEGF-Therapie: der "Vienna Fluid Monitor" in der klinischen Praxis.
Ophthalmologe
; 119(5): 520-524, 2022 May.
Article
em De
| MEDLINE
| ID: mdl-35420354
ABSTRACT
The Vienna fluid monitor is an artificial intelligence (AI) algorithm for the precise localization and quantification of retinal fluid. The algorithm is designed to help clinicians to make objective and accurate decisions in the anti-vascular endothelial growth factor (anti-VEGF) therapy of patients with neovascular age-related macular degeneration. The goal of the implementation is to optimize patient safety, preserve visual function and simultaneously to reduce the treatment burden on the healthcare system and patients.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Degeneração Macular Exsudativa
/
Ranibizumab
Tipo de estudo:
Diagnostic_studies
/
Prognostic_studies
Limite:
Humans
Idioma:
De
Revista:
Ophthalmologe
Ano de publicação:
2022
Tipo de documento:
Article